The Role of Combined 68Ga-DOTANOC and 18FDG PET/CT in the Management of Patients with Pancreatic Neuroendocrine Tumors

Publisher： Karger

E-ISSN： 1423-0194|100|4|293-299

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.100, Iss.4, 2014-10, pp. : 293-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of Multiphase 68Ga-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 91, Iss. 1, 2009-12 ,pp. : 101-109

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 103, Iss. 2, 2016-01 ,pp. : 153-171

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors

By  

Neuroendocrinology, Vol. 95, Iss. 2, 2011-12 ,pp. : 120-134

Karger

Access to resources Recommend Favorite

ENETS 2016 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: An Update

By  

Neuroendocrinology, Vol. 103, Iss. 2, 2016-01 ,pp. : 117-118

Karger

Access to resources Recommend Favorite

ENETS 2011 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: An Update

By  

Neuroendocrinology, Vol. 95, Iss. 2, 2011-12 ,pp. : 71-73

Karger

Access to resources Recommend Favorite